Assays for fixed dose combinations

Assays for fixed dose combinations

Assays to analyze quality and quantity attributes of fixed dose combinations are provided. In particular, assays for fixed dose combinations of two anti-HER2 antibodies, and for subcutaneous formulations comprising pertuzumab and trastuzumab are described herein.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HOLZMANN, NADINE, AVENAL, CECILE, RUCHTY, TANIA, SCHAEFER, GABRIELE M, ZAEHRINGER, FRANZISKA, NOAK, MICHAEL
Format: Patent
Sprache:chi ; eng
Schlagworte:
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HOLZMANN, NADINE
AVENAL, CECILE
RUCHTY, TANIA
SCHAEFER, GABRIELE M
ZAEHRINGER, FRANZISKA
NOAK, MICHAEL
description Assays to analyze quality and quantity attributes of fixed dose combinations are provided. In particular, assays for fixed dose combinations of two anti-HER2 antibodies, and for subcutaneous formulations comprising pertuzumab and trastuzumab are described herein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202217309A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202217309A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202217309A3</originalsourceid><addsrcrecordid>eNrjZFByLC5OrCxWSMsvUkjLrEhNUUjJL05VSM7PTcrMSyzJzM8r5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8SHhRgZGRobmxgaWjsbEqAEAsdAmLQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Assays for fixed dose combinations</title><source>esp@cenet</source><creator>HOLZMANN, NADINE ; AVENAL, CECILE ; RUCHTY, TANIA ; SCHAEFER, GABRIELE M ; ZAEHRINGER, FRANZISKA ; NOAK, MICHAEL</creator><creatorcontrib>HOLZMANN, NADINE ; AVENAL, CECILE ; RUCHTY, TANIA ; SCHAEFER, GABRIELE M ; ZAEHRINGER, FRANZISKA ; NOAK, MICHAEL</creatorcontrib><description>Assays to analyze quality and quantity attributes of fixed dose combinations are provided. In particular, assays for fixed dose combinations of two anti-HER2 antibodies, and for subcutaneous formulations comprising pertuzumab and trastuzumab are described herein.</description><language>chi ; eng</language><subject>CHEMISTRY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220501&amp;DB=EPODOC&amp;CC=TW&amp;NR=202217309A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220501&amp;DB=EPODOC&amp;CC=TW&amp;NR=202217309A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HOLZMANN, NADINE</creatorcontrib><creatorcontrib>AVENAL, CECILE</creatorcontrib><creatorcontrib>RUCHTY, TANIA</creatorcontrib><creatorcontrib>SCHAEFER, GABRIELE M</creatorcontrib><creatorcontrib>ZAEHRINGER, FRANZISKA</creatorcontrib><creatorcontrib>NOAK, MICHAEL</creatorcontrib><title>Assays for fixed dose combinations</title><description>Assays to analyze quality and quantity attributes of fixed dose combinations are provided. In particular, assays for fixed dose combinations of two anti-HER2 antibodies, and for subcutaneous formulations comprising pertuzumab and trastuzumab are described herein.</description><subject>CHEMISTRY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFByLC5OrCxWSMsvUkjLrEhNUUjJL05VSM7PTcrMSyzJzM8r5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8SHhRgZGRobmxgaWjsbEqAEAsdAmLQ</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>HOLZMANN, NADINE</creator><creator>AVENAL, CECILE</creator><creator>RUCHTY, TANIA</creator><creator>SCHAEFER, GABRIELE M</creator><creator>ZAEHRINGER, FRANZISKA</creator><creator>NOAK, MICHAEL</creator><scope>EVB</scope></search><sort><creationdate>20220501</creationdate><title>Assays for fixed dose combinations</title><author>HOLZMANN, NADINE ; AVENAL, CECILE ; RUCHTY, TANIA ; SCHAEFER, GABRIELE M ; ZAEHRINGER, FRANZISKA ; NOAK, MICHAEL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202217309A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>HOLZMANN, NADINE</creatorcontrib><creatorcontrib>AVENAL, CECILE</creatorcontrib><creatorcontrib>RUCHTY, TANIA</creatorcontrib><creatorcontrib>SCHAEFER, GABRIELE M</creatorcontrib><creatorcontrib>ZAEHRINGER, FRANZISKA</creatorcontrib><creatorcontrib>NOAK, MICHAEL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HOLZMANN, NADINE</au><au>AVENAL, CECILE</au><au>RUCHTY, TANIA</au><au>SCHAEFER, GABRIELE M</au><au>ZAEHRINGER, FRANZISKA</au><au>NOAK, MICHAEL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Assays for fixed dose combinations</title><date>2022-05-01</date><risdate>2022</risdate><abstract>Assays to analyze quality and quantity attributes of fixed dose combinations are provided. In particular, assays for fixed dose combinations of two anti-HER2 antibodies, and for subcutaneous formulations comprising pertuzumab and trastuzumab are described herein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_TW202217309A
source esp@cenet
subjects CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
title Assays for fixed dose combinations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A42%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HOLZMANN,%20NADINE&rft.date=2022-05-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202217309A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true